Fortitude Family Office »

Aardvark Therapeutics shares owned by Fortitude Family Office

Quarter-by-quarter ownership of Aardvark Therapeutics (AARD) shares owned by Fortitude Family Office from 13F filings

Historical chart of Fortitude Family Office investment in Aardvark Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aardvark Therapeutics held by Fortitude Family Office consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aardvark Therapeutics by Fortitude Family Office

Quarter filed Position value Share count Share price at filing
2026-06-30 $323 56 5.77

More positions owned by Fortitude Family Office

Ishares Core S&p 500 Etf Etf (IVV)
Avantis Total Equity Markets Etf Etf (AVTM)
Vanguard 0-3 Month Treasury Bill Etf Etf (VBIL)
Ishares Core Msci International Developed Markets Etf Etf (IDEV)
Dimensional Inflation-protected Securities Etf Etf (DFIP)
Imgp Dbi Managed Futures Strategy Etf Etf (DBMF)
Vanguard Mid-cap Etf Etf (VO)
Apple Stock (AAPL)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Vanguard S&p 500 Etf Etf (VOO)
Ishares Core Msci Emerging Markets Etf Etf (IEMG)
Avantis U.s. Large Cap Value Etf Etf (AVLV)
Dimensional Emerging Markets Core Equity 2 Etf Etf (DFEM)
Invesco Senior Loan Etf Etf (BKLN)
Ishares Msci Emerging Markets Ex China Etf Etf (EMXC)

View all positions for Fortitude Family Office

Top funds holding Aardvark Therapeutics

Decheng Capital
Citadel Advisors
Laurion Capital Management
Vanguard Capital Management
AQR Capital Management
EcoR1 Capital
Adage Capital Partners GP
State Street Corporation
BlackRock
Geode Capital Management
Cantor Fitzgerald, L. P.
Two Sigma Investments
Raymond James Financial
Vanguard Fiduciary Trust
Woodline Partners

View all funds holding Aardvark Therapeutics